Drug intelligence / Profile preview

ContiSol

Development stage
Unknown
Lead developer
B. Braun
Modality
Small Molecules
Administration
Intravesical
01

Overview

ContiSol is a sterile, bicarbonate-buffered electrolyte solution developed by B. Braun for use in continuous renal replacement therapy (CRRT). It is primarily indicated as a replacement fluid in continuous veno-venous hemofiltration (CVVH) and continuous veno-venous hemodiafiltration (CVVHDF) for patients suffering from acute kidney injury or renal failure. The solution is designed to maintain or restore physiological electrolyte levels and acid-base balance, containing essential ions such as sodium, calcium, magnesium, and chloride, along with bicarbonate as a buffering agent to correct metabolic acidosis. ContiSol is available in various formulations, such as ContiSol 0 and ContiSol 4, which differ in their potassium concentrations to allow for individualized patient management based on serum electrolyte levels. The product is typically supplied in a two-compartment bag to ensure the stability of the bicarbonate and electrolytes until the point of administration.

Brand names
ContiSol
Other names
ContiSol 0ContiSol0ContiSol-0ContiSol 2ContiSol2ContiSol-2ContiSol 4ContiSol4ContiSol-4
02

Targets

ClC (CLC chloride channel family)

Beyond the preview

Go deeper on ContiSol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ContiSol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call